Health Affairs' Rob Lott interviews Keith Drake of Greylock McKinnon Associates about his recent paper that explores trends ...

The offer is the latest in a series of deals by Concentra, an investment vehicle controlled by Tang Capital Partners, to buy ...

Similarly, resistance to Trop-2-targeted Sacituecan in TNBC has been linked to increased drug efflux activity mediated by MDR transporters ... the potential to significantly enhance the treatment ...

DataM Intelligence | competitive Intelligence NPC's treatment landscape is changing fast, with new FDA approvals and a promising pipeline s ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

NF1 drug development accelerates with novel treatments aiming to surpass current MEK inhibitors in efficacy, safety, and patient-friendly delivery. The evolving NF1 landscape highlights how innovation ...

Angola has begun constructing a €100 million drug plant to produce injectables and tablets. • The facility, led by Thera, will produce up to 35 million injectables and two billion tablets a year by ...

By Carlos Aguilar Crossing the concrete landscape of Los Angeles on public transport with precious cargo, Raquel (Sofia Yepes), a queer Latina aspiring to become a major music producer, is also ...

Infrastructure Development and Technological Advancements: ...

Rett syndrome care is evolving as DAYBUE leads the market and next-gen therapies like gene and neuroplasticity agents aim to redefine treatment standards Rett syndrome’s future lies in altering ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day.

Whether you want to relive the second summer of love and the late-Eighties acid house rave scene or just want to feel what it ...